Cite

    Adrien Rousseau et al.. “Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.” European journal of cancer, vol. 182, 2023, pp. 107–114. http://access.bl.uk/ark:/81055/vdc_100179403854.0x000031